임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

31건 표시

3상모집 중· Varicella (Chickenpox)
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
리드: GC녹십자
상세 →NCT07054099
3상모집 중· Chronic Liver Disease
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
리드: GC녹십자
상세 →NCT06493799
3상모집 중· Hepatitis B
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
리드: GC녹십자
상세 →NCT05686759
3상모집 중단 (진행 중)· Primary Immune Deficiency
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
상세 →NCT04565015
3상완료· BCG Vaccination Reaction
A Study of GC3107(BCG Vaccine) in Healthy Infants
리드: GC녹십자
상세 →NCT03947138
3상철회· Primary Immune Deficiency Disorder
Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
상세 →NCT03492710
3상완료· MPS II
An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)
리드: GC녹십자
상세 →NCT07344376
3상상태 미확인· Influenza Vaccine
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
리드: GC녹십자
상세 →NCT03285997
3상완료· Hunter Syndrome
A Study of GC1111 in Hunter Syndrom Patients
리드: GC녹십자
상세 →NCT03920540
3상완료· Influenza, Human
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older
리드: GC녹십자
상세 →NCT02917304
3상상태 미확인· Influenza, Human
A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults
리드: GC녹십자
상세 →NCT02915809
3상완료· Immunologic Deficiency Syndromes
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
상세 →NCT02783482
3상상태 미확인· Healthy
Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult
리드: GC녹십자
상세 →NCT02553837
3상상태 미확인· Influenza
A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study
리드: GC녹십자
상세 →NCT02658409
3상완료· Influenza
A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children
리드: GC녹십자
상세 →NCT02541253
3상완료· Influenza
A Multicenter, Double-blind, Parallel Phase III Study
리드: GC녹십자
상세 →NCT02352584
3상완료· Immune Thrombocytopenia
An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
리드: GC녹십자
상세 →NCT02063789
3상완료· Bacterial Infections
To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults
리드: GC녹십자
상세 →NCT02361866
3상상태 미확인· Hemophilia A
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
리드: GC녹십자
상세 →NCT02027779
3상완료· Influenza
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
리드: GC녹십자
상세 →NCT01987011
3상완료· Prophylaxis Against Influenza
To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults
리드: GC녹십자
상세 →NCT01750814
3상상태 미확인· Hemophilia A
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
리드: GC녹십자
상세 →NCT01619046
3상완료· Chronic Fatigue Syndrome
Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients
협력: GC녹십자
상세 →NCT01742013
3상완료· Thyroid Disease
Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy
리드: GC녹십자
상세 →NCT01696305
3상완료· Hunter Syndrome
Safety and Efficacy of Hunterase
리드: GC녹십자
상세 →NCT01645189
3상완료· Immunologic Deficiency Syndrome
Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
리드: GC녹십자
상세 →NCT01406470
3상조기 종료· Severe Sepsis
GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
리드: GC녹십자
상세 →NCT01315496
3상완료· Influenza Infection
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
리드: GC녹십자
상세 →NCT01201902
3상완료· Osteoarthritis
Efficacy and Safety of Shinbaro Capsule
리드: GC녹십자
상세 →NCT01535417
3상완료· Infection
Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS
리드: GC녹십자
상세 →NCT02360514
3상완료· Hemophilia A
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
리드: GC녹십자
상세 →NCT01568580

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.